Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.
about
Combined bacterial and viral treatment: a novel anticancer strategyVaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges.Pros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesThe March Toward Malaria VaccinesSpontaneous restoration of transplantation tolerance after acute rejection.32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect.A Genetically Modified attenuated Listeria Vaccine Expressing HPV16 E7 Kill Tumor Cells in Direct and Antigen-Specific Manner.The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cellsProgress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure.Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma.Tumor-targeted delivery of a C-terminally truncated FADD (N-FADD) significantly suppresses the B16F10 melanoma via enhancing apoptosis.Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery.Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors.Immunotherapy for canine cancer--is it time to go back to the future?The march toward malaria vaccines.Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic Cells.Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.Combined Extract of Heated 4T1 and a Heat-Killed Preparation of Lactobacillus Casei in a Mouse Model of Breast Cancer.Carboxyl-Terminal Residues N478 and V479 Required for the Cytolytic Activity of Listeriolysin O Play a Critical Role in Listeria monocytogenes Pathogenicity.Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice.Two is better than one: advances in pathogen-boosted immunotherapy and adoptive T-cell therapy.Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.Attenuated Bacteria as Immunotherapeutic Tools for Cancer Treatment.Listeria Monocytogenes: A Model Pathogen Continues to Refine Our Knowledge of the CD8 T Cell Response.White paper on microbial anti-cancer therapy and preventionas a Vector for Cancer Immunotherapy: Current Understanding and Progress
P2860
Q26773180-B256D148-DC24-40BF-80BB-2361DB99509EQ26796314-5AC66028-DF86-4899-A62C-8D291C10B428Q27013679-ED12DA6A-B027-4ED8-8DD0-D163BB622709Q28084325-BF6B3BF5-C235-4900-A439-056A75A55C49Q30657418-A1BB4459-F356-435B-B25E-3077A00DF5D9Q33591328-3AF05FFF-EAD4-41B2-83B6-7A58F9EE067DQ33849628-94B07773-0595-46B0-A00E-123D0631DD89Q35832233-15FFD4F4-2B95-460E-B26A-B78BC6D471D9Q36781992-CD47B90C-C9A2-4DB3-AA48-606BCE1F1750Q37086138-E3068F2E-D49A-4674-8585-72364E8C1C9BQ37355548-B04FD625-54B8-4E8A-A213-4829C0CECDA5Q37502444-2D59209A-5704-4F96-BD83-A90D890DEB8EQ37612527-B4287460-736A-4431-808D-28F24CB4EC6FQ38363923-E3C974F5-C7AA-4BB6-BE2F-8C2960D54417Q38577638-4A556481-A79E-40F0-8513-7CEAAADFF26DQ39450802-8DD88664-A15E-4F80-AAD1-6260A8E8EB31Q41174284-3FF1D577-92BE-4204-ADF0-5625DA122B5FQ41412439-DEC09574-EBAB-4448-8046-B0BAF7F6E3F2Q47100482-C1409C64-56AC-4D9C-8159-B7ADC6348329Q47105902-C6447EC3-F610-41C8-A588-0586B032FD16Q47559036-9F264B6E-3CD4-408E-ABA1-06A25285A415Q47709474-A406F2EC-9A3D-42F0-97F5-38BA1DABA3F9Q53159624-2F94D73A-48D8-4F47-B1B6-7B429D6D7C61Q55025711-AB66FEA8-0C29-4B44-9D85-0890F14520BFQ55645457-51CAD62C-18DB-408D-BED3-EEBBAEFA3FC0Q56898750-6C9298DA-D141-4D1D-85D8-C8E580618FC6Q58924835-4AB2ABC9-CE2C-492E-B241-0A2EFFEE3D8B
P2860
Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Attenuated Listeria monocytoge ...... future of tumor immunotherapy.
@ast
Attenuated Listeria monocytoge ...... future of tumor immunotherapy.
@en
type
label
Attenuated Listeria monocytoge ...... future of tumor immunotherapy.
@ast
Attenuated Listeria monocytoge ...... future of tumor immunotherapy.
@en
prefLabel
Attenuated Listeria monocytoge ...... future of tumor immunotherapy.
@ast
Attenuated Listeria monocytoge ...... future of tumor immunotherapy.
@en
P2860
P921
P356
P1476
Attenuated Listeria monocytoge ...... future of tumor immunotherapy
@en
P2093
Laurence M Wood
P2860
P356
10.3389/FCIMB.2014.00051
P5008
P577
2014-05-12T00:00:00Z